🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the effects of treatment with XOMA 052 on beta-cell function and ...
Status
Completed
Location
University Hospital Basel
Start Date
2009-09
Trial ID
NCT01788033
The purpose of this study is to evaluate the long-term safety of gevokizuma...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02293564
Treatments Being Tested
The objective of this study is to evaluate long-term safety of gevokizumab ...
Status
Terminated
Location
Lions Eye Institute
Start Date
2014-08
Trial ID
NCT02375685
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of gevokizumab in red...
Status
Terminated
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01747538
Treatments Being Tested
The study will evaluate the safety and biologic activity of gevokizumab in ...
Status
Completed
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01882504
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of gevokizumab in the...
Status
Terminated
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01684345
Treatments Being Tested
The purpose of this study is to evaluate the safety and pharmacokinetics (P...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00513214
The purpose of this proof-of-concept study is to determine whether gevokizu...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01683396
Treatments Being Tested
The purpose of this proof-of-concept study is to determine whether gevokizu...
Status
Completed
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01882491
Treatments Being Tested
This study will look at the recurrence-free survival of microsatellite-stab...
Status
Withdrawn
Location
UF Health Davis Cancer Pavilion and Shands Med Plaza
Start Date
2022-06-24
Trial ID
NCT05178576
Treatments Being Tested